Regenerative Medicine

Most interventional pain treatments work by interrupting a pain signal — numbing a nerve, disabling its ability to fire, or modulating how it's processed. Regenerative treatments take a different approach: they aim to support the tissue itself, using a patient's own biology — concentrated platelets, or a biologic scaffold — to encourage healing in tendons, joints, ligaments, or discs that haven't recovered fully on their own.

That distinction matters for how these treatments fit into a broader plan. They're not typically a first-line intervention, and they're not a replacement for conservative care or established procedures with a longer track record — they're a targeted option for select patients whose tissue, not just their pain signaling, appears to be the thing standing in the way of recovery.

The evidence base varies meaningfully across this category. Platelet-rich plasma has a growing, increasingly credible body of research behind it, particularly for certain tendons and joints. Intradiscal biologic treatment for the disc is newer and more selectively studied — real, but still developing. Dr. Foster is direct about that difference with patients rather than presenting every regenerative option as equally established.

In practice, that means regenerative treatment is offered when the specific evidence and the specific patient line up — not as a default add-on, and not oversold as a guaranteed fix. For many patients, it's one option among several, weighed against the alternatives on this site with the same honesty applied everywhere else: what it offers, what the risks are, and how confident the evidence actually is.